Admera Health snags Series A funds
South Plainfield, New Jersey-based Admera Health, a molecular diagnostics company, has closed an undisclosed amount of Series A funding. Prime Value Capital Management led the round with participation from Sungent Bioventure. Also, PVCM’s founding partner, Dr. Chenhui Wen, has been added to Admera Health's board of directors.
7 April 2015•3 mins read
